Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03381846 · ClinicalTrials.gov registry record · NA
Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger
A NA study of Dermatofibrosarcoma Protuberans, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03381846: Completed NA study of Dermatofibrosarcoma Protuberans, sponsored by Mayo Clinic.
NCT03381846 is a NA study of Dermatofibrosarcoma Protuberans that has completed, run by Mayo Clinic. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03381846, a NA study of Dermatofibrosarcoma Protuberans, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to explore the challenges that providers face which may prevent them performing this potentially superior treatment. This study will provide a comparison of outcomes and recurrence rates in pediatric patients treated by MOHS versus traditional excision.
Primary Outcome
Developing an additional dermatofibrosarcoma protuberans at any location, but particularly noting local recurrence (defined as being within or contiguous to the field of the previous excision.
Conditions Studied
Interventions
- PROCEDURE MOHS micrographic surgery
- PROCEDURE Wide local excision
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
What the finished NCT03381846 record still lists
NCT03381846 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Dermatofibrosarcoma Protuberans appearing as the primary indexed condition, and to 2 interventions - of which MOHS micrographic surgery is the first listed.
NCT03381846 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03381846 about?
NCT03381846 is a clinical study titled "Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger". The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to explore the challenges tha...
What is the current status of trial NCT03381846?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-07-01. Estimated completion is 2020-06-30.
What conditions does trial NCT03381846 study?
This clinical trial studies the following conditions: Dermatofibrosarcoma Protuberans.
What interventions are being tested in trial NCT03381846?
The interventions under investigation include: MOHS micrographic surgery (PROCEDURE), Wide local excision (PROCEDURE).
Who is sponsoring clinical trial NCT03381846?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03381846 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03381846's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI